Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples